In summary, our findings suggest that APOE ε4 and older Δ age contribute synergistically to risk of AD and a variety of age-related neurological diseases and dysfunction (Fig 6B), and APOE ε4 is unlikely to increase risk by simply increasing the rate of brain aging. This evidence concerns the gene APOE and Alzheimer disease.